Navigation Links
Medco Announces Date for Release of First-Quarter 2011 Financial Results

FRANKLIN LAKES, N.J., April 13, 2011 /PRNewswire/ -- Medco Health Solutions, Inc. (NYSE: MHS) plans to announce its first-quarter 2011 financial results in a press release before the market opens on Thursday, April 28, 2011.  


Following the release, management will hold a conference call to review the financial results, outlook and related matters at 8:30 a.m. ET.  

To access the live conference call via telephone:

Dial in: (800) 949-5383 from inside the U.S., or (706) 679-3440 from outside the U.S.  

To access the live webcast:

Visit the Investor Relations section at

For a replay of the call:

A replay of the call will be available after the event on April 28, 2011 through May 12, 2011.  Dial in: (800) 642-1687 from inside the U.S., or (706) 645-9291 from outside the U.S.  Please use passcode 59704342.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenues of nearly $66 billion, Medco ranks 35th on the 2010 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.  

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medcos Willingboro Automated Pharmacy: 500 Million Prescriptions and Counting
2. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
3. CalPERS Notifies Medco of Renewal Decision
4. Medco Tops Industry on Fortunes List of Worlds Most Admired Companies for Fourth Consecutive Year
5. Medco to Present at the Citi 2011 Global Health Care Conference
6. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
7. Medco Announces Date for Release of Fourth-Quarter and Full-Year 2010 Financial Results
8. Medco CEO to Present at Upcoming Healthcare Conferences
9. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
10. Medcos 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating
11. Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):